US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
San Diego biotech gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
California biotech company gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
GlobalData on MSN1d
Sooma gains FDA approval to commence study of tDCS device
Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...
Fierce Pharma8h
Amid Vafseo's US launch, Akebia plots phase 3 study to grow CKD anemia med's reach
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...
The Manila Times4d
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...
Managed Healthcare Executive1d
FDA Approves First Generics of Xarelto
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...
The Manila Times2d
PharmaTher Receives US FDA Approval Goal Date for Ketamine
"I am very pleased with the new FDA approval goal date of June 4, 2025 for our Ketamine drug. We are focused on solving the shortage issue of Ketamine and becoming the leading supplier of Ketamine to ...
Zydus gains FDA approval for urinary tract infection medication
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.
STAT13h
Trump’s picks to run FDA and NIH win approval from Senate’s health committee
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.